account_num,net_change,tag,tag_depth,cik
2841,-4571000.0,TaxesPayableCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2431,1185000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1781,-13587000.0,NonoperatingGainsLosses,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1025,1420000.0,AmortizationOfIntangibleAssets,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
845,1420000.0,AmortizationOfDeferredCharges,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1572,753000.0,FinanceLeaseRightOfUseAsset,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
707,21531000.0,SellingAndMarketingExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3426,-7225000.0,AccruedIncomeTaxesNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3395,-7225000.0,AccountsPayableAndAccruedLiabilitiesNoncurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
856,2200000.0,RestrictedInvestmentsCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2286,1185000.0,NetIncomeLossAttributableToRedeemableNoncontrollingInterest,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1378,-13587000.0,DeconsolidationGainOrLossAmount,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2877,-4571000.0,AccruedIncomeTaxesCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1478,-1177000.0,IncomeLossFromEquityMethodInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3917,-741987000.0,LiabilitiesAndStockholdersEquity,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
581,76191000.0,OperatingCostsAndExpenses,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1549,235000.0,RestrictedCashAndCashEquivalentsAtCarryingValue,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1071,2435000.0,RestrictedCashAndInvestmentsCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
229,88804000.0,AccountsReceivableNetCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
207,88804000.0,AccountsNotesAndLoansReceivableNetCurrent,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
320,88804000.0,ReceivablesNetCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
455,103584000.0,InventoryNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
260,103584000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
868,378319000.0,AssetsCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1634,25554000.0,OperatingLeaseRightOfUseAsset,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1368,238266000.0,PropertyPlantAndEquipmentNet,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1827,37298000.0,IntangibleAssetsNetIncludingGoodwill,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2041,20856000.0,OtherAssetsNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2091,363668000.0,AssetsNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2089,741987000.0,Assets,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2347,-84242000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2737,-3046000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2638,-3046000.0,DebtCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1079,235000.0,RestrictedCashCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
577,175762000.0,CashCashEquivalentsAndShortTermInvestments,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
645,156098000.0,CashAndCashEquivalentsAtCarryingValue,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2004,-9068000.0,OtherNonoperatingIncomeExpense,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2257,-116040000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2399,23477000.0,IncomeTaxExpenseBenefit,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1820,-139517000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1077,-91386000.0,ProfitLoss,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1912,-91386000.0,NetIncomeLoss,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2590,-91386000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2903,-91386000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
281,19664000.0,ShortTermInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1494,2414000.0,EquityMethodInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1557,2414000.0,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures,6,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1626,2414000.0,LongTermInvestments,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1848,2414000.0,LongTermInvestmentsAndReceivablesNet,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1901,38527000.0,DeferredIncomeTaxAssetsNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2552,-4571000.0,AccruedLiabilitiesCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3383,-144000.0,DeferredIncomeTaxLiabilitiesNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3494,-14565000.0,OtherLiabilitiesNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3817,189524000.0,TreasuryStockValue,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3809,-8624000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
144,250127000.0,CostOfRevenue,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
491,74771000.0,ResearchAndDevelopmentExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
456,1420000.0,DepreciationAndAmortization,4,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2149,-117886000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1854,1846000.0,InterestAndDebtExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1709,1846000.0,InterestExpense,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
2130,-8543000.0,NonoperatingIncomeExpense,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3154,-94862000.0,LiabilitiesCurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3303,-72839000.0,LongTermDebtAndCapitalLeaseObligations,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3379,-23694000.0,OperatingLeaseLiabilityNoncurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3796,-45628000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3645,-118467000.0,LiabilitiesNoncurrent,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3465,-213329000.0,Liabilities,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3661,-6000.0,CommonStockValue,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3750,-455077000.0,AdditionalPaidInCapital,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3834,-271723000.0,RetainedEarningsAccumulatedDeficit,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3316,-924954000.0,StockholdersEquity,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
3260,-528658000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
232,-248860000.0,GrossProfit,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
597,45061000.0,GeneralAndAdministrativeExpense,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
601,66592000.0,SellingGeneralAndAdministrativeExpense,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1002,-141000.0,GainLossOnDispositionOfAssets1,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1112,141363000.0,OperatingExpenses,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1264,-107497000.0,OperatingIncomeLoss,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1340,-1321000.0,InvestmentIncomeInterest,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1563,-1321000.0,InvestmentIncomeInterestAndDividend,3,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1665,-1321000.0,InvestmentIncomeNet,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
1205,-14908000.0,InvestmentIncomeNonoperating,2,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
173,-498987000.0,Revenues,1,"1297184_AMPHASTAR PHARMACEUTICALS, INC."
